Incyte (INCY) Debt Ratio (2012 - 2026)

Incyte's (INCY) quarterly Debt Ratio came in at 0.0 in Q2 2026, down 38.73% YoY from 0.01 in Q2 2025, and down 8.13% on a QoQ basis from 0.01 in Q1 2026.

Incyte (INCY) Debt Ratio (2012 - 2026) Analysis & Trends

Incyte (INCY) has 14 years of Debt Ratio data on file, last reported at 0.0 in Q2 2026.

  • Quarterly Debt Ratio fell 38.73% year-over-year to 0.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.0 (down 38.73% YoY) and the FY2025 annual result came in at 0.01, down 17.95% from the prior year.
  • Debt Ratio declined to 0.0 in Q2 2026, from 0.01 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.01 in Q3 2024 to a low of 0.0 in Q2 2026.
  • A 5-year average of 0.01 and a median of 0.01 in 2022 frame the typical range for Debt Ratio.
  • Annual changes were most pronounced in 2024 — Debt Ratio soared 39.63% — and 2026, when it slumped 38.73%.
  • Tracing INCY's Debt Ratio over 5 years: stood at 0.01 in 2022, then retreated by 9.44% to 0.01 in 2023, then increased by 27.22% to 0.01 in 2024, then dropped by 17.95% to 0.01 in 2025, then retreated by 16.63% to 0.0 in 2026.
  • The last three Debt Ratio figures came in at 0.0 (Q2 2026), 0.01 (Q1 2026), and 0.01 (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.05
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.12
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.47
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.26
10 Incyte 24.15 Bn 19.61 Bn 1.57 Bn 0.00

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Mar 31, 2026 0.01
Dec 31, 2025 0.01
Sep 30, 2025 0.01
Jun 30, 2025 0.01
Mar 31, 2025 0.01
Dec 31, 2024 0.01
Sep 30, 2024 0.01
Jun 30, 2024 0.01
Mar 31, 2024 0.01
Dec 31, 2023 0.01
Sep 30, 2023 0.01
Jun 30, 2023 0.01
Mar 31, 2023 0.01
Dec 31, 2022 0.01
Sep 30, 2022 0.01
Jun 30, 2022 0.01
Mar 31, 2022 0.01
Dec 31, 2021 0.01
Sep 30, 2021 0.01